Objective: To determine how isoflurance affects the longitudinal distribution of pulmonary vascular resistance and pulmonary gas exchange during Escherichia coli bacteremia.
Design: Prospective, controlled study with open-label assignment of animals to two groups.
Setting: Laboratory.
Subjects: Goehingen minipigs.
Interventions: Induction of acute respiratory failure by a 4-hr infusion of live E. coli bacteria in 12 animals; six animals anesthetized with methohexital/piritramide; six animals anesthetized with isoflurane. The control group consisted of four animals that received the same surgical procedure, but no E. coli infusion. Two animals were anesthetized with methohexital/piritramide and two with isoflurane, respectively.
Measurements And Main Results: Cardiac output and pressures were measured by means of an arterial catheter, Swan-Ganz catheter, and a left atrial catheter. Effective pulmonary capillary pressure was evaluated graphically from a pulmonary artery occlusion pressure decay. Arterial-alveolar PO2 ratio was calculated to evaluate pulmonary function. Measurements were performed before and after 1, 2, and 3.5 hrs of E. coli infusion. Statistical significance was tested with analysis of variance (ANOVA). E. coli infusion caused hypodynamic shock, an increase in pre- and postcapillary pulmonary vascular resistance and respiratory failure. Postcapillary pressure gradient and effective pulmonary capillary pressure were lower in the isoflurane-group. Methohexital-anesthetized animals developed pulmonary dysfunction after 1 hr of bacteremia, whereas isoflurane-anesthetized animals developed pulmonary dysfunction after 3.5 hrs of E. coli infusion (significantly different, ANOVA, p < .05). There were no significant changes in the sham group.
Conclusions: Isoflurane is a pulmonary venodilator. During lethal E. coli infusion, it ameliorates the increase in pulmonary capillary pressure and preserves pulmonary function until vascular permeability increases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00003246-199305000-00019 | DOI Listing |
Transfus Apher Sci
December 2024
Alexion, AstraZeneca Rare Disease, 121 Seaport Blvd, Boston, MA 02210, USA. Electronic address:
Plasma exchange (PE) outcomes in patients with trigger-associated thrombotic microangiopathy (TMA) have not been comprehensively reviewed. Embase and MEDLINE® were searched on 03/14/2022 for English language articles published after 2007, alongside a congress materials search (2019-2022; PROSPERO: CRD42022325170). Studies with patients with trigger-associated TMA (excluding thrombotic thrombocytopenic purpura, 'typical' hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli, post-partum TMA, and TMAs with known genetic cause) who received PE or plasma infusion (PI) and reported treatment response (including measures), safety, patient-/caregiver-reported outcomes, or economic burden data were examined.
View Article and Find Full Text PDFInt J Biol Macromol
December 2024
Department of Electrical Engineering, South Tehran Branch, Islamic Azad University, Tehran, Iran.
Biological macromolecules such as polysaccharides and proteins, due to their excellent biocompatibility and biodegradability, are ideal for promoting Skin Tissue Engineering (STE) both in vitro and in vivo. In this study, a core-shell electrospun scaffold was fabricated using the coaxial electrospinning method, with Polyurethane (PU) forming the shell and a mixture of Starch (ST), Propolis Extract (PE), and Hyaluronic Acid (HA) forming the core. The scaffold's morphology was characterized by Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM), confirming the successful formation of a well-defined core-shell structure.
View Article and Find Full Text PDFInt J Biol Macromol
December 2024
Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China; The Institute of Vascular Diseases, Central South University, Changsha, China. Electronic address:
The high incidence of skin wounds (e.g., burns, diabetic ulcers, venous ulcers, pressure sores, and radiation injuries) remains a significant challenge in clinical settings.
View Article and Find Full Text PDFInt J Biol Macromol
December 2024
Food Engineering and Packaging Division, Defence Food Research Laboratory, Mysore 570011, India.
Chitosan-based films incorporated with green-synthesized TiO nanoparticles (CT) and Averrhoa carambola extract (CP) at different concentrations were fabricated and optimised based on enhanced tensile, moisture-gas barrier and retention capabilities of antioxidants. Chitosan incorporated with 0.06 % TiO NP and those incorporated with 6 % carambola extract exhibited optimal results, and developed films of the above two concentrations of the additives were blended into chitosan (CTP) for further analysis.
View Article and Find Full Text PDFInt J Biol Macromol
December 2024
Department of Pulp & Paper Engineering, College of Light Industry and Food Engineering, Nanjing Forestry University, Nanjing 210037, PR China. Electronic address:
This study presents the ex situ development and characterization of bacterial cellulose (BC) membranes loaded with bioactive Sage and Neem extracts for enhanced antimicrobial applications. Utilizing discarded fruit waste as a cost-effective carbon source, BC production was optimized, yielding membranes with improved properties. Neem and Sage extracts, obtained via Soxhlet extraction, exhibited significant antibacterial activity against Escherichia coli and Staphylococcus aureus, with minimum inhibitory concentrations of 3.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!